Global Clinical Trial Imaging Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Clinical Trial Imaging Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

According to our (Global Info Research) latest study, the global Clinical Trial Imaging market size was valued at US$ 1520 million in 2023 and is forecast to a readjusted size of USD 2392 million by 2030 with a CAGR of 6.8% during review period.

Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

This report is a detailed and comprehensive analysis for global Clinical Trial Imaging market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Clinical Trial Imaging market size and forecasts, in consumption value ($ Million), 2019-2030

Global Clinical Trial Imaging market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Clinical Trial Imaging market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Clinical Trial Imaging market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Clinical Trial Imaging

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Clinical Trial Imaging market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Clinical Trial Imaging market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Clinical Trial Imaging market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
In-house Imaging Service
Central Imaging Service

Market segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others

Market segment by players, this report covers
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Clinical Trial Imaging product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Clinical Trial Imaging, with revenue, gross margin, and global market share of Clinical Trial Imaging from 2019 to 2024.

Chapter 3, the Clinical Trial Imaging competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Clinical Trial Imaging market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Trial Imaging.

Chapter 13, to describe Clinical Trial Imaging research findings and conclusion.